Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure October 2009, Vol 11, No 4
© The Authors. Journal Compilation © 2009 Blackwell Publishing Ltd and Medicalhelplines.com Inc. International Wound Journal, 2009, Vol 6, No 1 pages: 67–72. ABSTRACT Previous studies have shown that an epidermal growth factor-based formulation (Heberprot-P) can enhance granulation of high-grade diabetic foot ulcers (DFU). The aim of this study was to explore the clinical effects […]
